A detailed history of Pnc Financial Services Group, Inc. transactions in Biovie Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 474 shares of BIVI stock, worth $1,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
474
Previous 421 12.59%
Holding current value
$1,312
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.4 - $0.56 $21 - $29
53 Added 12.59%
474 $0
Q1 2024

May 10, 2024

BUY
$0.53 - $1.89 $223 - $795
421 New
421 $0

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $83.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.